Skip to main content

Table 1 Characteristics of patients with vespid or bee venom allergy

From: Quality-of-life in insect venom allergy: validation of the Turkish version of the “Vespid Allergy Quality of Life Questionnaire” (VQLQ-T)

  Apis Vespula
Number 81 65
Age (years)* 42.33 ± 12.58 39.2 ± 13.06
[46 (18–70)] [38 (17–70)]
Gender   
 Female, no (%) 34 (42 %) 33 (51 %)
 Male, no (%) 47 (58 %) 32 (49 %)
Severity of systemic reactions (%)
 Grade I 9 (11.1) 5 (7.7)
 Grade II 21 (26) 25 (38.5)
 Grade III 24 (29.6) 15 (23)
 Grade IV 27 (33.3) 20 (30.8)
Patient groups for cross-sectional validation
 New diagnosis 18 (22.2) 23(35.4)
 Recently started (up-dosing) VIT 30 (37) 18 (27.7)
 Receiving on maintenance VIT 22 (27.2) 16 (24.6)
 Stopped VIT 11 (13.6) 8 (12.3)
  1. For the variables with *, cells represent mean ± standard deviation [median (min–max)], for the others, cells represent frequency (percent). VIT venom immunotherapy